Summus-affiliated physician Dr. David Penson, Chair of the Department of Urologic Surgery at Vanderbilt, was recently featured in an LA Times article discussing the diagnosis of prostate cancer. In the article, Dr. Penson discusses improvements over simple PSA tests. Read the full article from the LA Times here.
Prostate cancer diagnosis: are there better options than a simple PSA test?
Search Posts
YOU MAY ALSO LIKE
Related Posts
Employee benefits leaders face unprecedented pressure to deliver meaningful healthcare support, all while navigating rising costs, reducing complexity, and proving...
We’re honored to share that Summus has been named to TIME’s list of the World’s Top HealthTech Companies of 2025....
Cancer is one of the most devastating and costly conditions facing employees and their employers. Each year, cancer accounts for...
Healthcare costs continue to rise, employee expectations are shifting, and benefit leaders are under more pressure than ever to deliver...